LDS/Medical Tests/TBP (TATA box binding protein) Gene Mutation Analysis

TBP (TATA box binding protein) Gene Mutation Analysis

The TBP gene, which is located in the long (q) arm of chromosome 6 at position 27 encode a protein called the TATA box binding protein. This protein is active in cells and tissues throughout the body, where it plays an essential role in regulating the activity of most genes. TBP protein is a subunit of transcription factor IID (TFIID), which plays a role in the activation of eukaryotic genes transcribed by RNA polymerase II. The TBP protein binds to a particular sequence of DNA known as the TATA box and takes part in transcription. One region of the TBP gene contains a particular DNA segment known as a CAG/CAA trinucleotide repeat. This segment is made up of a series of three DNA building blocks (nucleotides) that appear multiple times in a row. Normally, the CAG/CAA segment is repeated 25 to 40 times within the gene. Expansion of the number of repeats in the TBP gene is associated with Huntington disease-like 4 (HDL4) or spinocerebellar ataxia type 17 (SCA17).

SCA17 is an autosomal dominant cerebellar ataxia (ADCA) characterized by widespread cerebral and cerebellar atrophy, dementia and involuntary movements, including chorea and dystonia. The number of CAG/CAA repeats determines the clinical phenotype although exact genotype/phenotype correlations are difficult to predict due to penetrance. Individuals with 41-48 repeats may or may not develop symptoms such as intellectual deterioration, or Parkinsonism. TBP genes with 49 or more CAG/CAA repeats are considered ‘full-penetrance’ and patients invariably develop features of SCA17. Although the exact pathogenesis of SCA17 is not completely understood it is believed that an increased number of CAG/CAA repeats in the TBP gene leads to the production of an abnormally long version of the TATA binding protein with and elongated polyglutamine ‘tail’ at the N-terminus. It is believed that the extra glutamines at the N-terminus modulates the binding of the C-terminus to DNA and confers a gain of function in the activity of TBP. The diagnosis of SCA17 is based on identification of an abnormal CAG/CAA repeat expansion in TBP.

  • As an aid in diagnosis of spinocerebellar ataxia type 17 (SCA17) in patients with cerebellar ataxia and dementia
  • Screening relatives with the family history and those higher risk
  • Prenatal screening in pregnancy at increased risk and preimplantation genetic testing
  • To assist with prognosis, clinical management and surveillance for disease features based on the genetic variant involved

Normal alleles - 25 to 40 CAG/CAA repeats

Reduced-penetrance alleles - 41 to 48 CAG/CAA repeats. An individual with an allele in this range may or may not develop symptoms.

Full-penetrance alleles - 49 or greater CAG/CAA repeats. The repeat size may reach up to 66.

< 40 CAG/CAA repeats

Targeted analysis for CAG/CAA repeats expansion by PCR, Next generation sequencing, Bi-directional Sanger Sequence Analysis, repeat expansion Gel electrophoresis.

Whole blood.

Stability

  • Ambien: 3-5 days
  • Refrigerated: 7-14 days
  • Frozen: Unacceptable
Deletion/duplication analysis, pathogenic variants analysis in HTT, PRNP, JPH3 genes.
1-2 weeks.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Eur J Hum Genet. 2008;16: 215-22. [PMID: 18043721]
  • Adv Exp Med Biol. 2018;1049:219-231. [PMID: 29427105]
  • Ann Neurol. 2007 Jun;61: 607-10. [PMID: 17474109]
  • Neuroscience. 2005;133(4):863-72 [PMID: 15916858]
  • Genes Dev. 1999; 13: 3217–3230. [PMID: 10617571]
  • Parkinsonism Relat Disord. 2014 Jun;20(6):678-9. [PMID: 14967767]
  • J Neurol. 2003 Feb;250(2):161-3. [
  • GeneReviews® [Internet]. Available at: https://www.ncbi.nlm.nih.gov/books/NBK1438/
  • Genetics Home Reference. Available at: https://ghr.nlm.nih.gov/gene/TBP#